Clinical Trial Update: A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium [Phase 2]

View source ↗

Summary

This Phase 2 dose-ranging trial evaluated the efficacy and safety of oral AZD9668 at three dose levels in patients with chronic obstructive pulmonary disease on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD9668 (AZD9668)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-08-03